Medical University of South Carolina-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 121-130

  2. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

    The Lancet, Vol. 394, Núm. 10193, pp. 131-138

  3. Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections

    Clinical Infectious Diseases, Vol. 69, Núm. 10, pp. 1812-1816

2018

  1. Defining antimicrobial resistance in cystic fibrosis

    Journal of Cystic Fibrosis, Vol. 17, Núm. 6, pp. 696-704

2016

  1. BK channel regulation by phosphodiesterase type 1: A novel signaling pathway controlling human detrusor smooth muscle function

    American Journal of Physiology - Renal Physiology, Vol. 310, Núm. 10, pp. F994-F999

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222